C07D 335/06
Benzothiopyrans
Official title: Benzothiopyrans; Hydrogenated benzothiopyrans
C07D335/06 (Benzothiopyrans) appears on 465 US grants and 186 published applications in this corpus.
Search patents in C07D- Granted patents
- 465
- Published applications
- 186
- Assignees
- 206
- Inventors
- 977
- Latest grant
- 8 Oct 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 9 | 0 |
| 1977 | 9 | 0 |
| 1978 | 2 | 0 |
| 1979 | 5 | 0 |
| 1980 | 11 | 0 |
| 1981 | 8 | 0 |
| 1982 | 6 | 0 |
| 1983 | 5 | 0 |
| 1984 | 8 | 0 |
| 1985 | 5 | 0 |
| 1986 | 8 | 0 |
| 1987 | 10 | 0 |
| 1988 | 7 | 0 |
| 1989 | 18 | 0 |
| 1990 | 11 | 0 |
| 1991 | 14 | 0 |
| 1992 | 10 | 0 |
| 1993 | 21 | 0 |
| 1994 | 13 | 0 |
| 1995 | 22 | 0 |
| 1996 | 14 | 0 |
| 1997 | 21 | 0 |
| 1998 | 18 | 0 |
| 1999 | 17 | 0 |
| 2000 | 22 | 0 |
| 2001 | 16 | 3 |
| 2002 | 18 | 9 |
| 2003 | 16 | 19 |
| 2004 | 8 | 12 |
| 2005 | 6 | 18 |
| 2006 | 9 | 14 |
| 2007 | 8 | 9 |
| 2008 | 8 | 9 |
| 2009 | 5 | 6 |
| 2010 | 9 | 13 |
| 2011 | 4 | 9 |
| 2012 | 14 | 6 |
| 2013 | 3 | 5 |
| 2014 | 4 | 4 |
| 2015 | 6 | 6 |
| 2016 | 3 | 5 |
| 2017 | 4 | 2 |
| 2018 | 4 | 9 |
| 2019 | 4 | 6 |
| 2020 | 7 | 6 |
| 2021 | 8 | 4 |
| 2022 | 1 | 2 |
| 2023 | 2 | 3 |
| 2024 | 4 | 3 |
| 2025 | 0 | 1 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Thiobenzopyrans and their use in preparation of drugs for treatment of rheumatoid arthritis8 Oct 2024US 12,110,282 B2Hc Synthetic Pharmaceutical Co., Ltd.
- Flavone compounds for the treatment and prophylaxis of hepatitis B virus disease18 Jun 2024US 12,012,390 B2Hoffmann-La Roche Inc.
- Chromane-substituted, tetrahydroquinoline-substituted and thiochromane-substituted heteroarotinoids as anti-cancer agents28 May 2024US 11,993,573 B2The Board of Regents for Oklahoma State University
- Compounds for optically active devices16 Apr 2024US 11,958,819 B2Johnson & Johnson Surgical Vision, Inc.
- Heterocyclic acyl hydrazone linkers, methods and uses thereof26 Dec 2023US 11,850,287 B2Ontario Institute for Cancer Search (Oicr)
- Sulfine-Based Compounds for Generating Hydrogen Persulfide10 Sep 2026US 2026/0265055 A1Brown University
- Electrochemistry of certain polycyclic aromatic heterocycles as applied to rechargeable cells20 Aug 2026US 2026/0242403 A1
- Compounds for the Treatment of Neuromuscular Disorders16 Jul 2026US 2026/0199273 A1Nmd Pharma A/S
- Water-soluble heterocyclyl polymethine chromophores2 Oct 2025US 2025/0304545 A1The Regents of the University of California
- Smarca degraders and uses thereof21 Nov 2024US 2024/0383868 A1Kymera Therapeutics, Inc.
Most cited
By later US patents
- Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity220US 5,089,509 AAllergan, Inc. · 1992
- Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities164US 5,877,207 AAllergan Sales, Inc. · 1999
- Compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity158US 5,023,341 AAllergan, Inc. · 1991
- Acetylenes disubstituted with a phenyl group and a heterobicyclic group having retinoid-like activity154US 4,810,804 AAllergan, Inc. · 1989
- Condensed heterocyclic compounds154US 5,037,825 AHoffmann-La Roche Inc. · 1991